Publications by authors named "Toru Asano"

Claim this Profile
C
Clinical outcomes of endoscopic detachable snare ligation for colonic diverticular hemorrhage: Multicenter cohort study.
Katsumasa Kobayashi, Natsuki Miura, Yohei Furumoto, Kenji Ito, Mari Iseki, Toru Asano

Dig Endosc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Toru Ishikawa, Hidenori Toyoda, Toru Asano

Hepatol Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Koichi Takaguchi, Toru Asano

J Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis-related complications: A propensity score-matched study.
Ayako Sato, Sho Watanabe, Mari Iseki, Yurina Yamada, Ryohei Kobayashi, Toru Asano

Hepatol Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of refractory immune checkpoint inhibitor-induced colitis with infection.
Yukito Okura, Katsumasa Kobayashi, Yurina Yamada, Makoto Furuya, Naoki Kitano, Toru Asano

DEN Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Makoto Nakamuta, Toru Asano

Hepatol Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholangiocarcinoma With Rare Esophageal Metastasis.
Mana Matsuoka, Katsumasa Kobayashi, Yukito Okura, Takahito Nozaka, Ayako Sato, Toru Asano

ACG Case Rep J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Closure of an Acute Duodenal Perforation Occurring during Endoscopic Ultrasound Using Endoclips and Polyglycolic Acid Sheets with Fibrin Glue.
Mana Matsuoka, Katsumasa Kobayashi, Yukito Okura, Tomohiro Mochida, Takahito Nozaka, Toru Asano

Case Rep Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential therapy from entecavir to tenofovir alafenamide continuous entecavir monotherapy for patients with chronic hepatitis B.
Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, Makoto Nakamuta, Toru Asano

JGH Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis.
Ken Suzaki, Katsumasa Kobayashi, Mana Matsuoka, Yukito Okura, Takahito Nozaka, Toru Asano

Clin J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Makoto Nakamuta, Toru Asano

Infect Dis Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Detachable Snare Ligation Improves the Treatment for Colonic Diverticular Hemorrhage.
Katsumasa Kobayashi, Yohei Furumoto, Daisuke Akutsu, Mana Matsuoka, Takahito Nozaka, Toru Asano

Digestion· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.
Hidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe, Makoto Nakamuta, Haruki Uojima, Toru Asano

J Gastroenterol Hepatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
Hidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe, Makoto Nakamuta, Haruki Uojima, Toru Asano

J Gastroenterol Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study.
Akito Nozaki, Masanori Atsukawa, Chisa Kondo, Hidenori Toyoda, Makoto Chuma, Toru Asano

Hepatol Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy.
Yuka Hayakawa, Katsumasa Kobayashi, Naoya Sakamoto, Mana Matsuoka, Takahito Nozaka, Toru Asano

Clin J Gastroenterol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.
Hiroki Ikeda, Tsunamasa Watanabe, Masanori Atsukawa, Hidenori Toyoda, Koichi Takaguchi, Toru Asano

J Viral Hepat· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.
Hidenori Toyoda, Masanori Atsukawa, Haruki Uojima, Akito Nozaki, Hideyuki Tamai, Toru Asano

Open Forum Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.
Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, Koichi Takaguchi, Makoto Nakamuta, Toru Asano

Hepatol Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, Koichi Takaguchi, Chisa Kondo, Toru Asano

J Gastroenterol Hepatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study.
Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Tadashi Ikegami, Noritomo Shimada, Toru Asano

Hepatol Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan.
Hidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi, Tomonori Senoh, Kojiro Michitaka, Toru Asano

J Gastroenterol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
Masanori Atsukawa, Akihito Tsubota, Keizo Kato, Hiroshi Abe, Noritomo Shimada, Toru Asano

J Gastroenterol Hepatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease.
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Tadashi Ikegami, Noritomo Shimada, Toru Asano

Hepatol Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.
Masanori Atsukawa, Akihito Tsubota, Yohei Koushima, Tadashi Ikegami, Kouji Watanabe, Toru Asano

Hepatol Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis